Compare NATR & DHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NATR | DHY |
|---|---|---|
| Founded | 1972 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 250.0M | 240.4M |
| IPO Year | 1995 | 1998 |
| Metric | NATR | DHY |
|---|---|---|
| Price | $13.07 | $1.64 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $28.33 | N/A |
| AVG Volume (30 Days) | 173.0K | ★ 743.5K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 165.00 | N/A |
| EPS | ★ 0.48 | N/A |
| Revenue | ★ $480,144,000.00 | N/A |
| Revenue This Year | $7.76 | N/A |
| Revenue Next Year | $4.82 | N/A |
| P/E Ratio | $28.23 | ★ N/A |
| Revenue Growth | ★ 5.67 | N/A |
| 52 Week Low | $12.97 | $1.68 |
| 52 Week High | $28.14 | $2.13 |
| Indicator | NATR | DHY |
|---|---|---|
| Relative Strength Index (RSI) | 25.40 | 29.03 |
| Support Level | N/A | N/A |
| Resistance Level | $21.17 | $2.05 |
| Average True Range (ATR) | 0.38 | 0.02 |
| MACD | 0.16 | -0.00 |
| Stochastic Oscillator | 8.18 | 0.00 |
Natures Sunshine Products Inc is a natural health and wellness company mainly engaged in the manufacturing and direct selling of nutritional and personal care products. The following Companies' product lines include: General health: Assorted health products related to blood sugar, bone health, cellular health, etc. Immune: offer products that support and strengthen the human immune system, Cardiovascular: Ingredients to give the cardiovascular system optimum support. Digestive: regulates intestinal and digestive functions, Personal care: personal care products for external use, and Weight management: to simplify the weight management process by providing healthy meal replacements. Business segment: Asia, Europe, North America, Latin America, and Other. The majority of revenue is from Asia.
Credit Suisse High Yield Credit Fund is a diversified, closed-end management investment company. The Fund's principal investment objective is to generate current income. Capital appreciation is a secondary objective, pursued to the extent consistent with the Fund's primary income objective.